Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5532129 | Egyptian Journal of Medical Human Genetics | 2017 | 9 Pages |
Abstract
Circulating miRNA-21 could be a novel early diagnostic and prognostic biomarker for detection of HCC. Approaches interfering with the miRNA-21/PDCD4-axis, or releasing PDCD4 expression, may have a strong basis for therapeutic uses in cancer in the future.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Gamalat El Gedawy, Manar Obada, Ayman Kelani, Hala El-Said, Naglaa M. Ghanayem,